MiMedx Group, Inc.
General ticker "MDXG" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $872.5M (TTM average)
MiMedx Group, Inc. does not follow the US Stock Market performance with the rate: -16.6%.
Estimated limits based on current volatility of 2.0%: low 4.49$, high 4.68$
Factors to consider:
- Total employees count: 808 (-3.5%) as of 2025
- Top business risk factors: Execution of priorities, Capital raising, Market competition, Technological changes, Leadership retention
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [5.01$, 8.97$]
- 2026-12-31 to 2027-12-31 estimated range: [5.55$, 9.74$]
Financial Metrics affecting the MDXG estimates:
- Positive: with PPE of 15.4 at the end of fiscal year the price was very low
- Positive: 7.80 < Operating profit margin, % of 15.26
- Positive: 6.77 < Operating cash flow per share per price, % of 7.22
- Negative: negative Industry operating cash flow (median)
- Negative: Shareholder equity ratio, % of 74.87 > 63.63
- Positive: Return on assets ratio (scaled to [-100,100]) of 12.42 > 6.06
- Positive: Inventory ratio change, % of -0.68 <= 0
- Negative: negative Industry operating income (median)
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term MDXG quotes
Long-term MDXG plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $321.48MM | $348.88MM | $418.63MM |
| Operating Expenses | $284.36MM | $290.01MM | $354.74MM |
| Operating Income | $37.12MM | $58.87MM | $63.89MM |
| Non-Operating Income | $-6.48MM | $-1.57MM | $2.38MM |
| Interest Expense | $6.46MM | $0.00MM | $0.00MM |
| R&D Expense | $12.66MM | $12.34MM | $15.10MM |
| Income(Loss) | $30.63MM | $57.29MM | $66.26MM |
| Taxes | $-36.81MM | $15.30MM | $17.68MM |
| Other Income(Loss) | $-9.21MM | $0.42MM | $0.00MM |
| Net Income(Loss)* | $58.23MM | $42.42MM | $48.58MM |
| Stockholders Equity | $142.72MM | $193.11MM | $256.55MM |
| Inventory | $21.02MM | $23.81MM | $25.34MM |
| Assets | $239.05MM | $263.92MM | $342.65MM |
| Operating Cash Flow | $26.77MM | $66.20MM | $74.00MM |
| Capital expenditure | $1.99MM | $1.68MM | $1.03MM |
| Investing Cash Flow | $-2.15MM | $-9.58MM | $-6.89MM |
| Financing Cash Flow | $-8.57MM | $-34.20MM | $-5.41MM |
| Earnings Per Share** | $0.50 | $0.29 | $0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.